UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.445-455

2011

Volltextzugriff (PDF)

Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.436-444

2011

Volltextzugriff (PDF)

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

Alzheimer's & dementia, 2009, Vol.5 (1), p.18-29

2009

Volltextzugriff (PDF)

Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease

Neurological research (New York), 2005-12, Vol.27 (8), p.869-881

2005

Volltextzugriff (PDF)

Inflammation and Alzheimer's disease pathogenesis

Neurobiology of aging, 1996-09, Vol.17 (5), p.681-686

1996

Volltextzugriff (PDF)

The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

Journal of neuropathology and experimental neurology, 2000-04, Vol.59 (4), p.308-313

2000

Volltextzugriff (PDF)

High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease

Biochemical and biophysical research communications, 1999-04, Vol.257 (3), p.787-791

1999

Volltextzugriff (PDF)

2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Journal of medicinal chemistry, 1998-03, Vol.41 (7), p.1060-1067

1998

Volltextzugriff (PDF)

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A β peptides of Alzheimer's disease

Biochimica et biophysica acta, 1998-04, Vol.1406 (3), p.291-298

1998

Volltextzugriff (PDF)

Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition

Neuroscience letters, 2000-03, Vol.283 (1), p.9-12

2000

Volltextzugriff (PDF)

Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels

Biochemical and biophysical research communications, 1998-11, Vol.252 (3), p.711-715

1998

Volltextzugriff (PDF)

Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease

Biochemistry (Easton), 2002-09, Vol.41 (37), p.11080-11090

2002

Volltextzugriff (PDF)

Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (∗)

The Journal of biological chemistry, 1996-02, Vol.271 (8), p.4077-4081

1996

Volltextzugriff (PDF)

Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma

Biochemical and biophysical research communications, 2000-02, Vol.268 (3), p.750-756

2000

Volltextzugriff (PDF)

Apolipoprotein E Alters Metabolism of AβPP in Cells Engaged in β-Amyloidosis

Journal of neuropathology and experimental neurology, 1999-03, Vol.58 (3), p.288-295

1999

Volltextzugriff (PDF)

Amyloid and lipids in the pathology of Alzheimer disease

Amyloid, 1999, Vol.6 (2), p.136-145

1999

Volltextzugriff (PDF)

Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease

The Journal of biological chemistry, 1996-08, Vol.271 (34), p.20631-20635

1996

Volltextzugriff (PDF)

β-Amyloid levels predict cholinesterase activity in human cerebrospinal fluid

Neuroreport, 1999-01, Vol.10 (1), p.127-130

1999

Volltextzugriff (PDF)

APP Transgenic Mice Tg2576 Accumulate Aβ Peptides That Are Distinct from the Chemically Modified and Insoluble Peptides Deposited in Alzheimer's Disease Senile Plaques

Biochemistry (Easton), 2002-01, Vol.41 (3), p.922-928

2002

Volltextzugriff (PDF)

Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism

The American journal of pathology, 2000-03, Vol.156 (3), p.797-805

2000

Volltextzugriff (PDF)

Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid Deposits

Biochemical and biophysical research communications, 1997-08, Vol.237 (1), p.188-191

1997

Volltextzugriff (PDF)

The role of complement in Alzheimer’s disease pathology

BBA - Molecular Basis of Disease, 2000-07, Vol.1502 (1), p.158-171

2000

Volltextzugriff (PDF)

Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man: Metabolic Profiling Implications and Pharmacology

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.3014-3018

1996

Volltextzugriff (PDF)

Oligomerization and fibril assembly of the amyloid-β protein

BBA - Molecular Basis of Disease, 2000-07, Vol.1502 (1), p.31-43

2000

Volltextzugriff (PDF)

Traumatic Brain Injury Increases β‐Amyloid Peptide 1‐42 in Cerebrospinal Fluid

Journal of neurochemistry, 1998-12, Vol.71 (6), p.2505-2509

1998

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(75)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease

Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease

Inflammation and Alzheimer's disease pathogenesis

The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease

2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A β peptides of Alzheimer's disease

Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition

Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels

Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease

Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (∗)

Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma

Apolipoprotein E Alters Metabolism of AβPP in Cells Engaged in β-Amyloidosis

Amyloid and lipids in the pathology of Alzheimer disease

Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease

β-Amyloid levels predict cholinesterase activity in human cerebrospinal fluid

APP Transgenic Mice Tg2576 Accumulate Aβ Peptides That Are Distinct from the Chemically Modified and Insoluble Peptides Deposited in Alzheimer's Disease Senile Plaques

Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism

Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid Deposits

The role of complement in Alzheimer’s disease pathology

Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man: Metabolic Profiling Implications and Pharmacology

Oligomerization and fibril assembly of the amyloid-β protein

Traumatic Brain Injury Increases β‐Amyloid Peptide 1‐42 in Cerebrospinal Fluid

Suchergebnisse filtern